Sybilla Biotech: in-silico drug discovery

Scritto da

LIVE WEB
THURSDAY 28th MAY, 6:00 PM

The scientists who founded Sibylla Biotech have developed the most advanced platform for in-silico drug discovery. Sibylla has in-licensed such a platform from the research institutions and Sibylla’s multidisciplinary team is further developing the technology. The innovation is based on applying innovative algorithms derived from advanced mathematical methods of theoretical physics to transformative drug discovery protocols. These proprietary techniques have enabled to reveal with atomic resolution the folding and misfolding mechanisms of bio-medically relevant proteins, thereby unveiling an entirely new class of pharmacological targets and at the same time enabling ultra-fast assessment of druggability of complex proteins, slashing development costs and computing time by order of magnitudes.

More info: https://mib.edu/en/programs/competence-centers/mib-lens/sybilla-biotech-in-silico-drug-discovery